What is the Future of Autoantibodies in Cancer Research?
The future of autoantibodies in cancer research is promising. Advancements in [proteomics] and [bioinformatics] are enabling the discovery of new autoantibodies and their associated TAAs. Moreover, the integration of autoantibody profiles with other omics data (such as genomics and metabolomics) could lead to more personalized and precise cancer diagnostics and therapeutics.
